EcoDrugPlus

Carbonic Anhydrase 2

Ensembl ID : ENSCAFG00020020231
Gene Symbol: CA2
3 Cross references
285 Possible Orthologues:

Carbonic Anhydrase 3

Ensembl ID : ENSCAFG00020020234
Gene Symbol: CA3
3 Cross references
310 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSCAFG00020002325
Gene Symbol: CA4
3 Cross references
334 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSCAFG00020004529
Gene Symbol: CA5A
3 Cross references
170 Possible Orthologues:

Carbonic Anhydrase 5b

Ensembl ID : ENSCAFG00020003679
Gene Symbol: CA5B
2 Cross references
184 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSCAFG00020007093
Gene Symbol: CA6
3 Cross references
227 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSCAFG00020017940
Gene Symbol: CA7
3 Cross references
221 Possible Orthologues:

Carbonic Anhydrase 9

Ensembl ID : ENSCAFG00020016632
Gene Symbol: CA9
3 Cross references
283 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSCAFG00020003490
Gene Symbol: CSNK1E
3 Cross references
265 Possible Orthologues:

Casein Kinase 2 Alpha 1

Ensembl ID : ENSCAFG00020004040
Gene Symbol: CSNK2A1
2 Cross references
138 Possible Orthologues:

Caspase 8

Ensembl ID : ENSCAFG00020003476
Gene Symbol: CASP8
3 Cross references
132 Possible Orthologues:

Caspase 9

Ensembl ID : ENSCAFG00020004802
Gene Symbol: CASP9
3 Cross references
204 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).